檢索結果 - Eric Jonasch

Refine Results
  1. 1
    MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma

    MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma 由 Elshad Hasanov, Eric Jonasch

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities

    Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities 由 Eric Jonasch, Frank G. Haluska

    出版 2001
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    NCCN Evidence Blocks

    NCCN Evidence Blocks 由 Robert W. Carlson, Eric Jonasch

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Renal cell carcinoma

    Renal cell carcinoma 由 Eric Jonasch, Jianjun Gao, W. Kimryn Rathmell

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Alternate sunitinib schedules in patients with metastatic renal cell carcinoma

    Alternate sunitinib schedules in patients with metastatic renal cell carcinoma 由 Sarathi Kalra, Brian I. Rini, Eric Jonasch

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    DDX3 regulates DNA damage-induced apoptosis and p53 stabilization

    DDX3 regulates DNA damage-induced apoptosis and p53 stabilization 由 Mianen Sun, Tong Zhou, Eric Jonasch, Richard S. Jope

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

    Clear cell renal cell carcinoma ontogeny and mechanisms of lethality 由 Eric Jonasch, Cheryl L. Walker, W. Kimryn Rathmell

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma

    Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma 由 Jonathan Verma, Eric Jonasch, Pamela Allen, Nizar Tannir, Anita Mahajan

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells

    The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells 由 Song Yi Ko, WonJae Lee, Melanie Weigert, Eric Jonasch, Ernst Lengyel, Honami Naora

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Cutaneous Squamous Cell Carcinoma and Inflammation of Actinic Keratoses Associated with Sorafenib

    Cutaneous Squamous Cell Carcinoma and Inflammation of Actinic Keratoses Associated with Sorafenib 由 Zita Dubauskas, Joy H. Kunishige, Víctor G. Prieto, Eric Jonasch, Patrick Hwu, Nizar M. Tannir

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules

    Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules 由 Bradley J. Atkinson, Sarathi Kalra, Xuemei Wang, Tharakeswara Bathala, Paul G. Corn, Nizar M. Tannir, Eric Jonasch

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    The Impact of Tyrosine Kinase Inhibitors on the Multimodality Treatment of Brain Metastases From Renal Cell Carcinoma

    The Impact of Tyrosine Kinase Inhibitors on the Multimodality Treatment of Brain Metastases From Renal Cell Carcinoma 由 Jonathan Verma, Eric Jonasch, Pamela K. Allen, Jeffrey S. Weinberg, Nizar M. Tannir, Eric L. Chang, Anita Mahajan

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events 由 Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma

    Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma 由 E. Jason Abel, Stephen H. Culp, Nizar M. Tannir, Surena F. Matin, Pheroze Tamboli, Eric Jonasch, Christopher G. Wood

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays

    An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays 由 Huifang Guo, Wenbin Liu, Zhenlin Ju, Pheroze Tamboli, Eric Jonasch, Gordon B. Mills, Yiling Lu, Bryan T. Hennessy, Dimitra Tsavachidou

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL

    Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL 由 Elshad Hasanov, G Chen, Pratim Chowdhury, Justin Weldon, Zhiyong Ding, Eric Jonasch, Subrata Sen, Cheryl L. Walker, Ruhee Dere

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Site-specific activation of AKT protects cells from death induced by glucose deprivation

    Site-specific activation of AKT protects cells from death induced by glucose deprivation 由 Meng Gao, Jingdan Liang, Yongling Lu, Huifang Guo, Polina German, Shanshan Bai, Eric Jonasch, Xingsheng Yang, G B Mills, Zhiyong Ding

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Randomized Controlled Trial of Expressive Writing for Patients With Renal Cell Carcinoma

    Randomized Controlled Trial of Expressive Writing for Patients With Renal Cell Carcinoma 由 Kathrin Milbury, Amy Spelman, Christopher Wood, Surena F. Matin, Nizar M. Tannir, Eric Jonasch, Louis L. Pisters, Qi Wei, Lorenzo Cohen

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Mammalian target of rapamycin (<scp>mTOR</scp>) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

    Mammalian target of rapamycin (<scp>mTOR</scp>) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes 由 Bradley J. Atkinson, Diana H. Cauley, Chaan S. Ng, Randall E. Millikan, Lianchun Xiao, Paul G. Corn, Eric Jonasch, Nizar M. Tannir

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake

    Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake 由 Song Yi Ko, Won‐Jae Lee, Hilary A. Kenny, Long H. Dang, Lee M. Ellis, Eric Jonasch, Ernst Lengyel, Honami Naora

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: